Vera Hoffman is the CEO and co-founder of Reveal Pharmaceuticals. She has directed startups and high growth enterprises from idea stage through global scale. Vera developed the initial business plan for Acquia ($1B exit); led teams across six continents to identify, plan, and execute new business opportunities for one of the world's largest companies; and guided the design, development, and commercialization of over a dozen innovative technology-based products. Vera is Principal Investigator of Reveal's SBIR grants, which are funded by the National Cancer Institute, the National Institute for Diabetes and Digestive and Kidney Diseases, and the National Heart, Lung and Blood Institute. She has degrees in Chemistry and Mathematics and an MBA from Harvard Business School.